M&T Bank
RNAM

M&T Bank’s Avidity Biosciences RNAM Stock Holding History

M&T Bank’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,227
Closed -$305K – 1785
2025
Q4 		$305K Buy
+4,227
New +$273K ﹤0.01% 1393

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

M&T Bank's RNAM Position: Q1 2026 in Review

M&T Bank sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,227 shares — an estimated $305K sold.

M&T Bank first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $305K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • M&T Bank reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • M&T Bank sold 4,227 Avidity Biosciences shares in Q1 2026, an estimated $305K.
  • M&T Bank first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • M&T Bank's Avidity Biosciences position peaked at $305K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.